Health IT Analytics September 18, 2018
Jennifer Bresnick

Amazon Web Services, Accenture, and Merck are creating a new cloud-based informatics research platform that aims to accelerate drug development.

Amazon Web Services (AWS), Accenture, and Merck have announced a collaboration to create a cloud-based informatics research platform to support advances in the life sciences.

The project will accelerate drug development by improving efficiency and innovation in the early stages of the development process, the companies said in a press release. Researchers will have access to new data aggregation and big data analytics capabilities with lower barriers to entry.

Standard application programming interfaces (APIs) will allow scientists to collaborate more effectively and conduct advanced research across disparate organizations.

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Cloud, Precision Medicine, Technology
Top 5 Azure AI Announcements From Microsoft Ignite 2024
Google Cloud launches AI Agent Space amid rising competition
KPMG Launches $100 Million AI Partnership With Google Cloud
Why Franciscan Health moved Epic to the Microsoft cloud
IBM Teams With AMD For Cloud AI Acceleration

Share This Article